FDA Inspection 1099275 — Sanofi Pasteur Limited

Sanofi Pasteur Limited — FEI 3002888623

The FDA completed an inspection of Sanofi Pasteur Limited on May 24, 2019 in North York. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 24, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
North York (Canada)